Clayton, Dubilier & Rice, LLC Covetrus, Inc. Transaction History

Clayton, Dubilier & Rice, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$13.8 - $20.82 $213,016 - $321,377	15,436 Added 0.05%	33,732,300 $700 Million
Q2 2021 Aug 13, 2021	BUY	$25.24 - $30.86 $1.01 Million - $1.24 Million	40,035 Added 0.12%	33,716,864 $910 Million
Q4 2020 Feb 09, 2021	BUY	$24.45 - $31.59 $202 Million - $261 Million	8,246,585 Added 32.43%	33,676,829 $968 Million
Q3 2020 Nov 10, 2020	BUY	$17.22 - $24.59 $247 Million - $353 Million	14,357,478 Added 129.66%	25,430,244 $620 Million
Q2 2020 Aug 11, 2020	BUY	$6.46 - $19.27 $40,620 - $121,169	6,288 Added 0.06%	11,072,766 $198 Million
Q1 2020 May 11, 2020	SELL	$5.64 - $15.23 $1.12 Million - $3.03 Million	-198,720 Reduced 1.76%	11,066,478 $90.1 Million
Q1 2019 Sep 13, 2019	BUY	$31.52 - $46.19 $355 Million - $520 Million	11,265,198 New	11,265,198 $362 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Clayton, Dubilier & Rice, LLC, based on Form 13F filings with the SEC.

Stay updated on Clayton, Dubilier & Rice, LLC with notifications on news.